Upgrade to SI Premium - Free Trial

Mallinckrodt (MNK)

0.34 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- M&A (3/31/18 *Est)

Latest Headlines

Keenova Champions Men's Health Month with Education and Outreach June 1, 2026 4:15 PM - PR NewsWire Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting May 15, 2026 7:37 AM - PR NewsWire Keenova Reports First Quarter 2026 Financial Results May 12, 2026 6:30 AM - PR NewsWire Keenova Launches New Consumer Campaign for Dupuytren's Contracture: Don't Be a Viking May 4, 2026 7:30 AM - PR NewsWire Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at Digestive Disease Week May 1, 2026 7:30 AM - PR NewsWire Keenova Therapeutics to Report First Quarter 2026 Financial Results on May 12, 2026 April 30, 2026 7:00 AM - PR NewsWire Keenova Announces Unaudited Fourth Quarter 2025 Financial Results March 31, 2026 6:30 AM - PR NewsWire Keenova Presents a New TERLIVAZ® (terlipressin) Clinical Analysis at the SHM Converge March 27, 2026 7:30 AM - PR NewsWire Full Article List